Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma

Published:2020-09-15 Issue:23 Volume:126 Page:5173-5183
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hu Jiyi¹²,Huang Qingting¹²,Gao Jing¹²,Guan Xiyin¹²,Hu Weixu¹²,Yang Jing¹²,Qiu Xianxin¹²,Chen Mingyuan³,Kong Lin²⁴,Lu Jiade J.¹²^ORCID

Affiliation:

1. Department of Radiation Oncology Shanghai Proton and Heavy Ion Center Shanghai China

2. Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy Shanghai China

3. Department of Nasopharyngeal Carcinoma Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China Guangdong China

4. Department of Radiation Oncology Shanghai Proton and Heavy Ion CenterFudan University Cancer Hospital Shanghai China

Funder

Science and Technology Commission of Shanghai Municipality

Shanghai Hospital Development Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33197

Reference25 articles.

1. Reirradiation of locally recurrent nasopharyngeal cancer: history, advances, and promises for the future

2. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: Efficacy and complications

3. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma

4. Salvage surgery for recurrent primary nasopharyngeal carcinoma

5. Intensity-Modulated Radiation Therapy in the Salvage of Locally Recurrent Nasopharyngeal Carcinoma

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy;BMC Cancer;2024-08-02

2. Effectiveness of mHealth intervention for trismus exercise in patients with head and neck cancer undergoing proton and heavy ion therapy: a randomized control trial;Supportive Care in Cancer;2024-06-29

3. Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities;The Lancet Oncology;2024-06

4. OSLD nanoDot characterization for carbon radiotherapy dosimetry;Physics in Medicine & Biology;2024-05-14

5. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy;Oral Oncology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3